|
|
|
|
|
09.04.26 - 22:09
|
Binah Capital Group Promotes Christopher Motta to President of World Equity Group (GlobeNewswire EN)
|
|
|
NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- Binah Capital Group (NASDAQ: BCG) (“Binah” or the “Company”) today announced that Christopher Motta has been promoted to President of World Equity Group (WEG), one of four broker-dealers owned and operated by Binah, based in the greater Chicago area. Motta most recently served as Chief Operating Officer of PKS Investments, another Binah subsidiary, where he spent five years strengthening the firm's operations and deepening its relationships with Binah's advisor network....
|
|
|
09.04.26 - 22:09
|
PROCEPT BioRobotics® to Report First Quarter 2026 Financial Results on April 29, 2026 (GlobeNewswire EN)
|
|
|
SAN JOSE, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the first quarter of 2026 after market close on Wednesday, April 29, 2026. The Company's management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time....
|
|
|
09.04.26 - 22:09
|
Pool Corporation Announces First Quarter 2026 Earnings Release Date and Conference Call (GlobeNewswire EN)
|
|
|
COVINGTON, La., April 09, 2026 (GLOBE NEWSWIRE) -- Pool Corporation (Nasdaq: POOL) announced today that the Company will release its first quarter 2026 earnings results before the market opens on April 23, 2026, and will hold a conference call to discuss the results at 10:00 a.m. Central Time (11:00 a.m. Eastern Time) that same day. The earnings release as well as a live webcast and replay of the conference call will be available on the Company's website at www.poolcorp.com. The conference call can also be accessed by dialing 1-888-348-8936 (domestic) or 1-412-902-4265 (international). ...
|
|
|
|
|
|
|
09.04.26 - 22:09
|
LifeVantage to Participate in Water Tower Research Insights Conference on Wednesday, April 15, 2026 (GlobeNewswire EN)
|
|
|
SALT LAKE CITY, April 09, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer, Kristen Cunningham, Chief Sales Officer, and Lisa Barnes, Vice President Research & Development and Regulatory, will participate in the upcoming Water Tower Research Insights Conference on Wednesday, April 15, 2026....
|
|
|
09.04.26 - 22:09
|
Latham Group, Inc. Announces First Quarter 2026 Earnings Release and Conference Call Date (GlobeNewswire EN)
|
|
|
LATHAM, N.Y., April 09, 2026 (GLOBE NEWSWIRE) -- Latham Group, Inc. (Nasdaq: SWIM), the largest designer, manufacturer, and marketer of in-ground residential swimming pools in North America, Australia, and New Zealand, today announced that it will release financial results for the first quarter 2026 on Tuesday, May 5, 2026, after the close of the U.S. market. The Company will hold a conference call to discuss the results that same day at 4:30 PM Eastern Time....
|
|
|
|
|
09.04.26 - 22:09
|
Commerce to Host Investor Briefing at Upcoming 2026 Commerce Live (GlobeNewswire EN)
|
|
|
AUSTIN, Texas, April 09, 2026 (GLOBE NEWSWIRE) -- Commerce.com, Inc. (Nasdaq: CMRC) (formerly BigCommerce Holdings, Inc.), a provider of an open, intelligent ecosystem of technology solutions that empower businesses to unlock data potential and deliver seamless, personalized experiences at scale, today announced that company management will host an investor briefing during the 2026 Commerce Live leadership conference in Chicago, Il....
|
|
|
|
|
|
|
|
|
09.04.26 - 22:09
|
LB Pharmaceuticals Announces Presentation at 25th Annual Needham Virtual Healthcare Conference (GlobeNewswire EN)
|
|
|
NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar depression, adjunctive major depressive disorder (MDD) and other neuropsychiatric diseases, today announced that Heather Turner, Chief Executive Officer, will present at the 25th Annual Needham Virtual Healthcare Conference on Thursday, April 16, 2026, at 11:45 a.m. ET....
|
|
|
09.04.26 - 22:09
|
Dynagas LNG Partners LP Announces Filing of Form 20-F With the SEC (GlobeNewswire EN)
|
|
|
ATHENS, Greece, April 09, 2026 (GLOBE NEWSWIRE) -- Dynagas LNG Partners LP (NYSE:DLNG) (the “Partnership”), an owner and operator of liquefied natural gas (“LNG”) carriers, announced today that it has filed its Annual Report on Form 20-F for the year ended December 31, 2025 (the “Annual Report”) with the U.S. Securities and Exchange Commission (the “SEC”)....
|
|
|
09.04.26 - 22:09
|
Exponent to Announce First Quarter of Fiscal Year 2026 Results and Host Quarterly Conference Call on April 30, 2026 (GlobeNewswire EN)
|
|
|
MENLO PARK, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), today announced that it will report First Quarter of fiscal year 2026 financial results for the period ended April 3, 2026 following the close of the market on Thursday, April 30, 2026. On that day, Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company's business and financial results....
|
|
|
|
|
09.04.26 - 22:09
|
Verrica Pharmaceuticals Announces Acceptance of Late-Breaking Abstract Highlighting Potential Abscopal Effect of VP-315 for the Treatment of Basal Cell Carcinoma at the Upcoming 2026 Society for Investigative Dermatology Annual Meeting (GlobeNewswire EN)
|
|
|
WEST CHESTER, Pa., April 09, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a therapeutics company developing and commercializing medications for the treatment of dermatological diseases, including skin cancers, today announced acceptance of a late-breaking abstract reporting Phase 2 exploratory data of VP-315, Verrica's novel oncolytic peptide for the treatment of basal cell carcinoma. The data will be presented at the upcoming 2026 Society for Investigative Dermatology (SID) Annual Meeting, which will take place from May 13-16, 2026, in Chicago, Illinois....
|
|
|
09.04.26 - 22:06
|
Credit Acceptance Named 2026 USA Today Top Workplaces Award Winner (GlobeNewswire EN)
|
|
|
Southfield, Michigan, April 09, 2026 (GLOBE NEWSWIRE) -- Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) has been named a 2026 USA Today Top Workplaces award winner for the sixth consecutive year. We made it into the Top 10 again this year, with a #4 ranking in the 1,000-2,499-employee size category....
|
|
|
|